SDZ:SWX
Sandoz Group AG
CHFÂ 72.90
arrow_upward
+1.36%(+0.98) 1D
Sep 29, 3:54:55 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZ...
Open
CHFÂ 71.98
High
CHFÂ 73.52
Low
CHFÂ 71.72
Mkt. cap
32.22B
Avg. vol.
1.57M
Volume
584.35K
Dividend
1.10%
Quarterly dividend
CHFÂ 0.20
Ex-dividend date
Apr 13, 2026
P/E ratio
59.67
52-wk high
CHFÂ 75.90
52-wk low
CHFÂ 43.86
EPS
CHFÂ 1.22
Shares outstanding
440.00M
No. of employees
20K
Open
CHFÂ 71.98
High
CHFÂ 73.52
Low
CHFÂ 71.72
Mkt. cap
32.22B
Avg. vol.
1.57M
Volume
584.35K
Dividend
1.10%
Quarterly dividend
CHFÂ 0.20
Ex-dividend date
Apr 13, 2026
P/E ratio
59.67
52-wk high
CHFÂ 75.90
52-wk low
CHFÂ 43.86
EPS
CHFÂ 1.22
Shares outstanding
440.00M
No. of employees
20K
News stories
From web sources and news partners
TipRanks
·
8 hours ago
Sandoz boosts European biosimilar capacity with new Slovenian plant
Yahoo! Finance Canada
·
4 days ago
Sandoz Group AG (D8Y0.HM) Stock Price, News, Quote & History
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG